Jillella Joins Fox Chase-Temple Bone-Marrow Transplant Program
PHILADELPHIA (Nov. 25, 2002) -- Medical oncologist Anand P. Jillella, M.D., of Ambler, Pa., recently became associate director of the Fox Chase-Temple Bone-Marrow Transplant Program and associate professor of medicine at Temple University School of Medicine. Fox Chase Cancer Center in Northeast Philadelphia and Temple University Hospital jointly conduct the Bone-Marrow Transplant Program.
Previously, Jillella directed the Stem-Cell Transplant Program at the Medical College of Georgia in Augusta and was a faculty member of the department of medicine there. In both 2001 and 2002, Jillella was recognized as one of America's Top Doctors by the Castle Connolly Guide.
Jillella earned his undergraduate degree at Spicer Memorial College in Poona, India, and his medical degree from Government Medical College in Kurnool. He completed his residency in internal medicine at the Medical College of Georgia in Augusta, where he served as chief medical resident.
While at the Medical College of Georgia, Jillella received the 1991 Resident Achievement Award and was inducted into the Alpha Omega Alpha honorary society in 1992. In 1993, Jillella earned the college's Nursing Staff Award for streamlining interaction between house medical staff and nursing services, the Resident Educator of the Year Award from the class of 1993 and the Outstanding Faculty Member of the Year Award from the house medical staff. Jillella also received the 1999 Outstanding Young Clinical Science Faculty Member of the Year Award from the Medical College of Georgia's faculty senate.
Jillella held a three-year postdoctoral fellowship in hematology and oncology at Yale University School of Medicine before returning to the Medical College of Georgia in 1996. In addition, he received intensive training in bone-marrow transplantation at Johns Hopkins Oncology Center in Baltimore.
Board-certified in medical oncology, Jillella is a fellow of the American College of Physicians. Other professional memberships include the American Society of Clinical Oncology and the American Association of Physicians from India.
Directed by nationally recognized hematologist Kenneth F. Mangan, M.D., the Fox Chase-Temple Bone-Marrow Transplant Program is an approved and certified transplant and stem-cell collection center for the National Marrow Donor Program. The Foundation for Accreditation of Hematopoietic Cell Therapy (FACT) has conferred prestigious Level 1 status on the joint program.
The program offers adult patients either donor (allogeneic) or self (autologous) bone-marrow transplants as well as transplants of stem cells from the bloodstream ("peripheral blood"). Transplant procedures let patients receive high-dose chemotherapy or radiation without suffering dangerous depletion of white and red blood cells and platelets.
The Fox Chase-Temple Bone-Marrow Transplant Program also offers "mini-transplants" of donor stem cells combined with low-dose chemotherapy or radiation. This approach harnesses a "graft-versus-tumor" effect, in which the donor cells attack the cancer. Because more easily tolerated drug or radiation doses are used with mini-transplants, they are appropriate for older patients and those who do not have a matched sibling donor.
Candidates for bone-marrow transplants include patients with leukemia, lymphoma or other cancers of the blood or bone marrow, aplastic anemia and related conditions. People with advanced cancers such as those of the breast, ovary, lung or kidney may benefit from peripheral-blood stem-cell transplants. Patients or physicians seeking more information for a possible referral may call the Fox Chase-Temple Bone-Marrow Transplant Program directly at 215-214-3100.
The joint Fox Chase-Temple Bone-Marrow Transplant Program, located on the campus of Temple-Jeanes Hospital, and the Fox Chase-Temple Cancer Center on the Temple University Hospital campus result from a collaborative effort between Fox Chase Cancer Center and Temple University Health System physicians to provide expert cancer diagnosis and treatment. Physicians from both institutions work together to offer patients access to the latest treatment options, clinical research and drug development.
The Fox Chase-Temple Cancer Center provides a complete range of the highest quality services to outpatients in a compassionate, comfortable setting. Support groups are available for patients and their families as well as on-site financial counseling to assist patients with concerns about payment for services. For more information on the Fox Chase-Temple Cancer Center, call 1-800-TempleMED or visit www.temple.edu/foxchasetemple.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.